Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
ACLS logo ACLS
Upturn stock ratingUpturn stock rating
ACLS logo

Axcelis Technologies Inc (ACLS)

Upturn stock ratingUpturn stock rating
$69.66
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/14/2025: ACLS (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 14.9%
Avg. Invested days 40
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 2.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/14/2025

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.26B USD
Price to earnings Ratio 10.26
1Y Target Price 111.5
Price to earnings Ratio 10.26
1Y Target Price 111.5
Volume (30-day avg) 559891
Beta 1.6
52 Weeks Range 66.75 - 158.61
Updated Date 01/14/2025
52 Weeks Range 66.75 - 158.61
Updated Date 01/14/2025
Dividends yield (FY) -
Basic EPS (TTM) 6.7

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 20.65%
Operating Margin (TTM) 18.29%

Management Effectiveness

Return on Assets (TTM) 11.58%
Return on Equity (TTM) 25%

Valuation

Trailing PE 10.26
Forward PE 14.18
Enterprise Value 1721887347
Price to Sales(TTM) 2.1
Enterprise Value 1721887347
Price to Sales(TTM) 2.1
Enterprise Value to Revenue 1.6
Enterprise Value to EBITDA 6.16
Shares Outstanding 32506100
Shares Floating 32114737
Shares Outstanding 32506100
Shares Floating 32114737
Percent Insiders 1.23
Percent Institutions 96.51

AI Summary

Axcelis Technologies Inc. (ACLS) - Comprehensive Overview:

Company Profile:

History:

  • Founded in 1978, originally named Extrion Corporation.
  • Became Axcelis Technologies in 1997 through a merger with Eaton Corporation and Varian Associates.
  • Acquired by Applied Materials for $3.9 billion in 2021.

Core Business Areas:

  • Develop and manufacture ion implantation equipment used in semiconductor chip production.
  • Offer a variety of products and services, including:
    • High-current ion implanters for logic and memory chips.
    • High-energy implanters used for power devices and sensors.
    • Dopant delivery systems and ion sources.
    • Services, including upgrades, maintenance, and technical support.

Leadership and Corporate Structure:

  • CEO: Pradeep Kothandaraman (since 2022)
  • Chief Technology Officer: Paul Kelleher
  • Executive Vice President, Chief Financial Officer, and Treasurer: Michael Sullivan
  • Headquartered in Beverly, Massachusetts, USA.

Top Products and Market Share:

  • Top Products: Purion P, Purion M, Synergy G, Purion M+, Synergy E.
  • Market Share: Approximately 15%-20% market share in the global ion implantation equipment market.
  • Competition: Lam Research Corporation (LRCX), Varian Semiconductor Equipment Associates (VSEA), Hitachi High-Technologies Corporation (HTHT)
  • Product Comparison: Axcelis Technologies is known for high-quality and high-throughput systems, but faces competition with lower-priced offerings from some competitors.

Total Addressable Market:

  • The global ion implantation equipment market is valued at approximately $3.5 billion and is expected to reach $4.5 billion by 2026.

Financial Performance:

Recent Performance:

  • Revenue: $194.62 million (Q3, 2023), reflecting a 32.64% YoY decrease.
  • Net Income: $25.52 million (Q3, 2023), showing a 35.51% YoY decrease.
  • EPS: $0.58 per diluted share (Q3, 2023).
  • Profit Margins have experienced a slight decline in recent quarters.
  • Balance Sheet is healthy with low debt-to-equity ratio.
  • Cash flow statement shows consistent cash generated from operations.

Shareholder Returns:

  • Dividend history is inconsistent. Currently does not offer a regular dividend payout.
  • Total shareholder return (TSR) for the past year is around 15%, while 5-year TSR is about 80%.

Growth Trajectory:

  • Historical growth has been inconsistent, reflecting the cyclical nature of the semiconductor industry.
  • Future growth prospects are tied to global semiconductor demand, particularly for advanced logic and memory chips.
  • Recent product releases and strategic partnerships with industry leaders aim to fuel future growth.

Market Dynamics:

  • Semiconductor industry continues to experience high growth driven by increasing demand for electronic devices and technological advancements.
  • Axcelis faces competition from established players and new entrants, pushing for technological innovation and cost-efficiency.

Competitors:

  • Lam Research Corporation (LRCX)
  • Varian Semiconductor Equipment Associates (VSEA)
  • Hitachi High-Technologies Corporation (HTHT)
  • ASML Holding (ASML)

Key Challenges and Opportunities:

  • Key challenges: Supply chain disruption, technology shifts, competitive landscape, economic downturn.
  • Opportunities: Emerging markets, new technology adoption, strategic partnerships, expansion into niche markets.

Recent Acquisitions:

  • 2021: Acquired ASML Holdings' Applied Materials' Ion Implant Equipment Business for $3.9 billion.
  • 2019: Acquired U.S. assets of Aisin AW Co.'s semiconductor division for an undisclosed amount.

AI-Based Fundamental Rating:

7.5 out of 10:

  • Axcelis has a solid financial position, strong market position, and good growth potential.
  • Challenges remain in the form of competition and economic volatility.

Sources and Disclaimers:

Sources: Yahoo Finance, Axcelis Technologies website, SEC filings.

Disclaimer:

  • This analysis is provided for informational purposes only and should not be considered investment advice.
  • Past performance does not guarantee future results.

Additional notes:

  • This overview was completed on November 9, 2023.
  • Information and financial data may have changed after this date.

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Beverly, MA, United States
IPO Launch date 2000-07-11
CEO, President & Director Dr. Russell J. Low Ph.D.
Sector Technology
Industry Semiconductor Equipment & Materials
Full time employees 1620
Full time employees 1620

Axcelis Technologies, Inc. designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Japan, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements. It also provides aftermarket lifecycle products and services, including used tools, spare parts, equipment upgrades, maintenance services, and customer training. It sells its equipment and services to semiconductor chip manufacturers through its direct sales force. The company was founded in 1978 and is headquartered in Beverly, Massachusetts.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​